Byung-Ki Cho
Chief Executive Officer bij BIONOTE, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Byung-Ki Cho is currently the Chief Executive Officer & Director at BioNote, Inc. He previously worked as the Director & Head-Research Center at Abbott Diagnostics Korea, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SD BIOSENSOR, INC.
0.12% | 28-03-2024 | 150 000 ( 0.12% ) | 1 M $ | 31-03-2024 |
Actieve functies van Byung-Ki Cho
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONOTE, INC. | Chief Executive Officer | 01-08-2020 |
Eerdere bekende functies van Byung-Ki Cho
| Bedrijven | Functie | Einde |
|---|---|---|
Abbott Diagnostics Korea, Inc.
 Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIONOTE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
